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Classroom-based cognitive behaviour therapy (FRIENDS): 
a cluster randomised controlled trial to Prevent Anxiety in 
Children through Education in Schools (PACES)
Paul Stallard, Elena Skryabina, Gordon Taylor, Rhiannon Phillips, Harry Daniels, Rob Anderson, Neil Simpson
Summary
Background Anxiety in children is common, impairs everyday functioning, and increases the risk of severe mental 
health disorders in adulthood. We investigated the eﬀ ect of a classroom-based cognitive behaviour therapy prevention 
programme (FRIENDS) on anxiety symptoms in children.
Methods Preventing Anxiety in Children though Education in Schools (PACES) is a three-group parallel cluster 
randomised controlled trial. Interventions were given between September, 2011, and July, 2012, with schools as the 
unit of allocation and individual participants as the unit of analysis. We enrolled state-funded junior schools in 
southwest England. We sent information to all eligible schools (state-funded junior schools in southwest England)
inviting them to enrol in the study. School year groups were assigned by computer-generated randomisation (1:1:1) to 
receive either school-led FRIENDS (led by teacher or school staﬀ  member), health-led FRIENDS (led by two trained 
health facilitators), or usual school provision. Children were not masked to treatment allocation. The allocated 
programme was given to all students (aged 9–10 years) in the school year (ie, universal delivery) as part of the school 
curriculum as nine, 60 min weekly sessions. Outcomes were collected by self-completed questionnaire administered 
by researchers masked to allocation. Primary outcome was symptoms of anxiety and low mood at 12 months assessed 
by the Revised Child Anxiety and Depression Scale (RCADS 30). Analyses were intention to treat and accounted for 
the clustered nature of the design. The study is registered, number ISRCTN23563048.
Findings 45 schools were enrolled: 14 (n=497 children) were randomly assigned to school-led FRIENDS, 14 (n=509) to 
health-led FRIENDS, and 12 (n=442) to usual school provision. 1257 (92%) children completed 12 month assessments 
(449 in health-led FRIENDS, 436 in school-led FRIENDS, and 372 in usual school provision). We recorded a diﬀ erence 
at 12 months in adjusted mean child-reported RCADS scores for health-led versus school-led FRIENDS (19·49 [SD 14·81] 
vs 22·86 [15·24]; adjusted diﬀ erence –3·91, 95% CI –6·48 to  –1·35; p=0·0004) and health-led FRIENDS versus usual 
school provision (19·49 [14·81] vs 22·48 [15·74]; –2·66, –5·22 to –0·09; p=0·043). We noted no diﬀ erences in parent or 
teacher ratings. Training teachers to deliver mental health programmes was not as eﬀ ective as delivery by health 
professionals. 
Interpretation Universally delivered anxiety prevention programmes can be eﬀ ective when used in schools. However, 
programme eﬀ ectiveness varies depending on who delivers them.
Funding National Institute for Health Research Public Health Research Programme.
Introduction
Anxiety disorders aﬀ ect 10% of children by the age of 
16 years.1 They signiﬁ cantly impair everyday functioning, 
often persist into adulthood, and increase the risk of other 
psychiatric disorders in adolescence and young adult hood.2–5 
The associated health-related burden, and economic and 
societal costs are large, and the need to improve the mental 
health of children is being increasingly recognised as a 
global priority.6–8
Eﬀ ective psychological interventions, especially cognitive 
behaviour therapy (CBT), are available for children with 
anxiety disorders.9,10 However, comparatively few children 
with anxiety disorders are identiﬁ ed and referred for 
treatment.11,12 The poor reach and availability of traditional 
treatment services has led to interest in more proactive 
preventive approaches with schools oﬀ ering a convenient 
and natural location to deliver such programmes.13,14
Findings of systematic reviews show that universal and 
targeted anxiety prevention programmes are often based 
on cognitive behaviour therapy.15 Data from reviews15,16 
suggest that cognitive behaviour therapy prevention 
programmes can be eﬀ ective, although research methods 
are poor, adequately powered implementation trials are 
scarce, results are inconsistent, and eﬀ ect sizes vary 
greatly. Most studies report overall changes in symptoms, 
and the preventive beneﬁ ts for less symptomatic 
participants have seldom been reported.
Prevention programmes can be universally provided to 
all of an identiﬁ ed population, or targeted towards those at 
risk of developing a disorder or showing early signs of a 
disorder, or a combination of both approaches.17 Universal 
programmes have good reach, avoid the need for 
screening, are less stigmatising, and oﬀ er the potential to 
enhance mental health and reduce present symptoms. 
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Targeted programmes focus scarce resources on in-
dividuals with greatest needs, and usually achieve larger 
treatment eﬀ ects.18,19
The eﬀ ect of the intervention leader (health vs school 
professional) has important implications for the method of 
delivery and sustainability of an intervention but has been 
directly investigated in only one study.20 Barrett and Turner 
noted that a universal anxiety prevention programme 
(FRIENDS; panel 1) was equally eﬀ ective in the reduction 
of symptoms of anxiety in children aged 10–12 years when 
given by a psychologist or teacher. However, systematic 
reviews have reached diﬀ erent conclusions about who is 
most eﬀ ective at delivering these programmes.15,16
Before anxiety prevention programmes can be endorsed 
and widely provided, independent implementation trials 
are needed to measure eﬀ ectiveness and cost-eﬀ ectiveness 
when provided under real-life conditions and to establish 
the eﬀ ect of the intervention leader on outcome.
We undertook a pragmatic assessment of the eﬀ ective-
ness of a classroom-based anxiety prevention programme 
(FRIENDS21) universally delivered by health and school 
professionals to school years 4 and 5 (children aged 
9–10 years) in UK junior schools. 
Methods
Study design and participants
We did this three-group parallel cluster randomised 
controlled trial between September, 2011, and July, 2012, 
with school as the unit of allocation and individual 
participants as the unit of analysis.22 A project information 
sheet and trial enrolment form was sent to all primary 
schools in Bath and northeast Somerset, Swindon 
Borough, and Wiltshire within a 50 mile radius of the 
University of Bath, UK (n=268). Eligible schools were 
state-funded junior schools in three Local Education 
Authorities in southwest England. Such junior schools are 
mainstream government-funded schools that are attended 
by 94·5% of children aged 5–10 years in the UK. All 
children aged 9–10 years (years 4 and 5) in participating 
schools were eligible, unless they were not attending 
school (eg, because of long-term sickness or excluded from 
school) or did not participate in Personal Social and Health 
Education (PSHE) lessons for religious or other reasons. 
The allocated intervention was given to all participants in 
the school year (ie, universal delivery) as part of the PSHE 
curriculum. The trial protocol is online.
Participation required written consent from the school 
head teacher, parents’ not opting their child out of the 
study, and signed assent from the child. The study was 
approved by the University of Bath, Department for 
Health Research Ethics Committee.
Randomisation and masking
Once all schools had been enrolled, we randomly assigned 
year groups (1:1:1) to school-led FRIENDS, health-led 
FRIENDS, or usual school provision. Randomisation was 
undertaken at school and not the class level to avoid 
possible contamination within schools. Trial groups were 
balanced with respect to key characteristics by calculating 
an imbalance statistic for a large random sample of 
possible allocation sequences.23 Children were not masked 
to treatment allocation. Outcomes were collected by self-
completed questionnaire administered by researchers 
masked to allocation. Group allocation was kept in a 
separate password-protected database. Researchers who 
analysed data were also masked to allocation—trial 
groups were numerically coded and data analysis 
undertaken masked to which code related to each trial 
group. The variables used for balancing were school size, 
number of students and classes, number of mixed 
classes, level of educational attainment, and preferred 
timetabling. A statistician with no other involvement in Figure: Trial proﬁ le
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45 schools enrolled
41 schools randomly assigned
4 did not confirm interest in time
14 schools assigned to 
health-led FRIENDS 
(n=509 children)
14 schools assigned to 
school-led FRIENDS 
(n=497 children)
12 schools assigned to
usual school provision 
(n=442 children)
1 withdrew
20 did not
give 
consent
25 did not
give 
consent
41 did not 
give 
consent
489 children assented 472 children assented 401 children assented
486 completed assessment
3 did not complete 
assessment
462 completed assessment
10 did not complete 
assessment
391 completed assessment
10 did not complete 
assessment
6 withdrew
10 absent
24 left school
1 withdrew
12 absent
23 left school
2 withdrew
9 absent
18 left school
449 completed 12 month 
assessment
436 completed 12 month 
assessment
372 completed 12 month 
assessment
For more on the trial protocol 
see http://www.trialsjournal.
com/content/13/1/227/abstract
Panel 1: Acronym for the FRIENDS process
F Feelings
R Remember to relax
I I can do it. I can try my best
E Explore solutions and coping step plans
N Now reward yourself. You’ve done your best
D Don’t forget practice
S Smile. Stay calm for life
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the study randomly selected one sequence from a subset 
with the most desirable balance properties.
Procedures
Interventions were delivered in the academic year 
September, 2011, to July, 2012. The anxiety prevention 
programme we assessed (FRIENDS) is a manualised 
cognitive behaviour therapy intervention that has been 
identiﬁ ed as eﬀ ective.16,24 The programme was developed to 
be delivered in schools and provided to whole classes of 
children. FRIENDS is based on the principles of CBT and 
develops skills to counter the cognitive, emotional, and 
behavioural aspects of anxiety. Children develop emotional 
awareness and regulation skills, to identify and replace 
cognitions that increase anxiety with more balanced and 
functional ways of thinking and to develop problem-solving 
skills to confront and cope with situations and events that 
provoke anxiety. The inter vention trialled in this study 
consisted of nine, 60 min weekly sessions delivered to 
whole classes of children. Children had their own workbook 
and group leaders had a detailed session plan that speciﬁ ed 
key learning points, objectives, and core activities for each 
session. The feasibility and viability of delivering FRIENDS 
in UK schools has previously been established.25,26
In the health-led FRIENDS programme, each session 
was led by two trained health facilitators working along-
side the class teacher. All facilitators had at least an 
undergraduate university degree in a relevant discipline 
(eg, social science or education), appropriate professional 
backgrounds (eg, psychology, nursing, or education), or 
experience of working with children or young people. 
Initial 2 day training and supervision every 2 weeks were 
provided by accredited FRIENDS trainers. Supervision 
was in a group format and consisted of review of session 
plans, the underlying cognitive model, class and behaviour 
management skills, and any interpersonal diﬃ  culties or 
communication problems with the class teacher.
In the school-led FRIENDS programme, sessions were 
led by a teacher or member of the school staﬀ  (eg, 
teaching assistant) who were trained in delivery of the 
programme and were supported by two facilitators. 
School staﬀ  attended the same 2 day initial training and 
were oﬀ ered ongoing supervision. We assessed treatment 
ﬁ delity by randomly assessing audiotape recordings of 
10% of FRIENDS sessions.
In the usual school provision programme, children 
participated in the usual PSHE sessions provided by the 
school. All schools were following a UK National 
Curriculum programme designed to develop self-
awareness, management of feelings, motivation, 
empathy, and social skills.27 The sessions were planned 
and provided solely by the teacher and did not include 
any external input from the research team.
Outcomes
Child outcomes were collected during class time with self-
completed questionnaires administered by researchers at 
baseline, 6 months, and 12 months. As described in the 
trial protocol,20 the primary outcome was symptoms of 
anxiety and low mood 12 months after baseline as 
established by the Revised Child Anxiety and Depression 
scale (RCADS 30).28,29 Secondary outcomes assessed worry 
(with the Penn State Worry Questionnaire for Children),30 
self-worth and acceptance (with the Rosenberg Self-Esteem 
Scale),31 extent of bullying (with the Olweus Bully/Victim 
Questionnaire), and life satisfaction (with a subjective 
wellbeing assessment).
Health-led FRIENDS 
(N=489)
School-led FRIENDS 
(N=472)
Usual PSHE 
(N=401)
Number of schools 14 14 12
Number of schools with ≥two classes 6 7 5
Class size 19·56 (6·56) 18·15 (7·68) 20·05 (8·29)
Missing baseline assessment 3 (0·6%) 10 (2·1%) 10 (2·5%)
Sex
Boys 255 (52·1%) 237 (50·2%) 170 (42·4%)
Girls 234 (47·9%) 235 (49·8%) 231 (57·6%)
Ethnic origin
British white 455 (94·2%) 439 (95·2%) 359 (92·1%)
Non-white 28 (5·8%) 22 (4·8%) 31 (7·9%)
Living situation
Mother and father 347 (71·4%) 315 (68·2%) 268 (68·5%)
Parent and partner 43 (8·8%) 55 (11·9%) 37 (9·4%)
Single parent 67 (13·8%) 68 (14·8%) 58 (14·8%)
Other 29 (6·0%) 24 (5·2%) 28 (7·2%)
Number of siblings
0 49 (10·1%) 30 (6·5%) 32 (8·2%)
1 221 (45·5%) 214 (46·5%) 184 (47·1%)
2 129 (26·5%) 134 (29·1%) 92 (23·5%)
3 or more 87 (17·9%) 82 (17·8%) 83 (21·2%)
Family aﬄ  uence
Low (0–2) 6  (1·5) 11 (2·4) 13 (3·3)
Medium (3–5) 142 (29·4) 139 (30·1) 128 (32·9)
High (6–8) 331 (69·1) 311 (67·5) 249 (63·8)
Child-completed assessments
Child total RCADS 26·24 (15·56) 24·91 (14·32) 26·78 (16·32)
Penn Worry Scale 10·63 (8·14) 10·99 (8·24) 10·46 (8·35)
Self-esteem 18·94 (5·34) 19·43 (5·39) 19·57 (5·98)
Total life satisfaction 14·21 (6·77) 13·32 (5·71) 13·76 (6·82)
Been bullied
Bullied ≥two to three times per month 142 (29·3%) 124 (26·8%) 112 (28·6%)
Not bullied or only once or twice 343 (70·7%) 338 (73·2%) 279 (71·4%)
Parent-completed assessments 217 (44·4%) 201 (42·6%) 153 (38·2%)
Total RCADS 12·55 (8·81) 10·99 (8·60) 12·52 (9·34)
Total SDQ 9·09 (6·32) 8·31 (6·28) 9·00 (6·24)
Teacher-reported assessment 487 (99·6%) 466 (98·7%) 396 (98·8%) 
Teacher SDQ impact
Diﬃ  culty 119 (24·4) 125 (26·8) 109 (27·5)
Data are mean (SD) or number (%) unless otherwise indicated. Family aﬄ  uence assessed by the Family Aﬄ  uence Scale.  
PSHE=personal social and health education. RCADS=Revised Child Anxiety and Depression Scale. SDQ=Strength and 
Diﬃ  culties Questionnaire. 
Table 1: Baseline characteristics
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Parents completed a behavioural screening question-
naire (Strength and Diﬃ  culties Questionnaire [SDQ])32 
and the parent version of the Revised Child Anxiety and 
Depression Scale (RCADS-30-P)33 at baseline, 6 months, 
and 12 months.
Class teachers completed the impact rating of the 
Strengths and Diﬃ  culties Questionnaire (SDQ) for all 
children in their class at all three assessment points 
to assess the presence of an emotional or behavioural 
problem, chronicity, distress, social impairment, and 
burden.
Statistical analysis
We powered the study to detect a diﬀ erence of 3·6 points 
in mean RCADS total scores between FRIENDS and usual 
PSHE. On the basis of an SD of 12 points and an 
intracluster correlation coeﬃ  cient of 0·02, 28 pupils per 
class, 90% consent and 80% retention, eﬀ ect sizes between 
0·28 and 0·30, SDs are detectable with 80% power and 5% 
two-sided α with 1134–1360 assenting pupils.
We used descriptive statistics to assess balance between 
the trial groups at baseline. The primary outcome was 
assessed by intention to treat without imputation. To take 
 Health-led FRIENDS School-led FRIENDS Usual school provision
Baseline 12 months Baseline 12 months Baseline 12 months p value overall 
group eﬀ ect*
Child reported 
N 489 449 472 436 401 372 ··
Penn Worry Scale 10·63 (8·14) 8·19 (7·93) 10·99 (8·24) 9·62 (8·30) 10·46 (8·35) 9·03 (8·52) 0·136
Self-esteem 18·94 (5·34) 20·90 (6·22) 19·43 (5·39) 20·77 (5·82) 19·57 (5·98) 20·87 (5·95) 0·639
Total life satisfaction 14·21 (6·77) 13·87 (6·00) 13·32 (5·71) 13·73 (6·08) 13·76 (6·82) 13·95 (5·88) 0·770
Bullied more ≥2–3 times per month 142 (29·3%) 74 (16·5%) 124 (26·8%) 98 (22·5%) 112 (28·6%) 86 (23·2%) 0·156
Not bullied or once or twice 343 (70·7) 374 (83·5) 338 (73·2) 337 (77·5) 279 (71·4) 285 (76·8)
Parent reported 
N 217 173 198 159 152 119 ··
Total RCADS 12·55 (8·81) 10·76 (8·90) 10·99 (8·60) 9·82 (7·13) 12·52 (9·34) 10·03 (7·31) 0·816
Total SDQ 9·09 (6·32) 7·06 (6·00) 8·31 (6·28) 6·67 (5·62) 9·00 (6·24) 7·32 (9·95) 0·767
Total SDQ threshold ≥17 22 (10·5%) 15 (9·3%) 25 (13·0%) 11 (7·3%) 21 (14·4%) 9 (7·9%) 0·333
Teacher reported
N 487 (99·6%) 454 (92·8%) 466 (98·7%) 445 (94·3%) 396 (98·8%) 375 (93·5%) ··
Teacher SDQ impact 119 (24·4) 131 (28·9) 125 (26·8) 143 (32·1) 109 (27·5) 117 (31·2) 0·538
Data are mean (SD) scores or n (%). PSHE=personal social and health education. RCADS=Revised Child Anxiety and Depression Scale. SDQ=Strength and Diﬃ  culties Questionnaire *Between group diﬀ erences at 
12 months adjusted for baseline, sex, and school level eﬀ ects.
Table 3: Analysis of secondary outcomes for all children at 12 months for health-led FRIENDS, school-led FRIENDS and usual school provision (PSHE) 
Health-led FRIENDS Adjusted diﬀ erence 
(95% CI) at 
12 months: health-
led FRIENDS vs usual 
school provision
Adjusted diﬀ erence 
(95% CI) at 
12 months: health-
led FRIENDS vs 
school-led FRIENDS
School-led FRIENDS Adjusted diﬀ erence 
(95% CI) at 
12 months: school-
led FRIENDS vs usual 
school provision
Usual school provision p value 
overall 
group 
eﬀ ect*
Baseline 
n=489
12 months 
n=449
Baseline 
n=472
12 months 
n=436
Baseline
n=401
12 months
n=372
Depression 4·04 (2·60) 3·15 (2·53) –0·36 (–0·76 to 0·04) –0·34 (–0·82 to 0·14) 3·68 (2·34) 3·34 (2·51) –0·02 (–0·43 to 0·38) 3·85 (2·77) 3·47 (2·72) 0·120
Social anxiety 5·28 (3·28) 4·39(3·32) –0·41 (–0·94 to 0·12) –0·79 (–1·42 to –0·16) 5·05 (3·23) 5·04 (3·43) 0·38 (–0·16 to 0·91) 5·13 (3·26) 4·68 (3·37) 0·013
Separation 
anxiety
3·81 (3·34) 2·48 (2·94) –0·42 (–0·97 to 0·12) –0·42 (–1·07 to –0·23) 3·68 (3·14) 2·89 (2·96) 0·00 (–0·54 to 0·55) 4·23 (3·45) 3·07 (3·14) 0·190
Generalised 
anxiety
5·79 (3·80) 4·43 (3·56) –0·77 (-1·40 to –0·14) –0·89 (–1·64 to –0·14) 5·64 (3·54) 5·19 (3·64) 0·12 (–0·52 to 0·75) 5·97 (3·94) 5·15 (3·70) 0·011
Panic 2·85 (2·87) 2·03 (2·56) –0·34 (–0·78, 0·09) –0·37 (–0·89 to 0·15) 2·68 (2·79) 2·33 (2·74) 0·03 (–0·41 to 0·47) 2·97 (3·11) 2·42 (3·00) 0·157
OCD 4·56 (3·31) 3·43 (3·10) –1·99 (–0·71 to 0·31) –0·51 (–1·12 to 0·10) 4·45 (3·12) 3·99 (3·20) 0·31 (–0·21 to 0·83) 4·61 (3·22) 3·79 (3·20) 0·124
Total RCADS 26·24 (15·56) 19·49 (14·81) –2·66 (–5·22 to –0·09) –3·91 (–6·48 to –1·35) 24·91 (14·32) 22·86 (15·24) 1·28 (–1·30 to 3·87) 26·78(16·32) 22·48 (15·74) 0·009
Data are mean (SD) unless otherwise stated· PSHE=personal social and health education· RCADS=Revised Child Anxiety and Depression Scale· OCD=obsessive compulsive disorder· *RCADS adjusted for sex, 
school, and baseline RCADS.
 Table 2: Analysis of primary outcome (child-completed RCADS) for all children at 12 months for health-led FRIENDS and school-led FRIENDS vs PSHE
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appropriate account of the hierarchical nature of the data, 
we used multivariable mixed eﬀ ects models to compare 
mean RCADS at 12 months for health-led FRIENDS with 
school-led FRIENDS and usual school provision, with 
adjustment for baseline RCADS, sex, and school eﬀ ects. 
We repeated these analyses for secondary outcomes. For 
RCADS we undertook a further planned analysis. We used 
repeated-measures mixed-eﬀ ects analysis of variance 
models to investigate convergence and divergence between 
trial groups over time. We did preplanned subgroup 
analyses with interaction terms in the regression models 
between the randomised group and the baseline variable 
(low anxiety RCADS 0–48, high anxiety ≥49).
We did sensitivity analyses to assess the potential eﬀ ect of 
missing data. Completion rates for all groups at 12 months 
were high (91·8–92·7%), although non-completers tended 
to be more symptomatic on our primary outcome measure 
(RCADS) at baseline (data not shown). With multiple 
imputation methods, we created 20 datasets and showed 
that imputation for missing data made no material 
diﬀ erence to the overall results.34 Therefore, the data we 
present are based on recorded data only.
The study is registered, number ISRCTN23563048.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, interpretation of data, or writing 
of the report. The corresponding author had full access 
to all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
Results
Between September, 2011, and July, 2012, 45 schools were 
enrolled. 41 consented to participate and were randomly 
assigned: 14 (n=497 children) to school-led FRIENDS, 
14 (n=509) to health-led FRIENDS, and 12 (n=442) to usual 
school provision. One school from usual school provision 
withdrew before baseline assessments were undertaken 
(ﬁ gure). The remaining 40 schools were representative of 
the UK in terms of academic attainment according to 
Department of Education performance tables (ie, the 
percentage of children achieving key stage 2 level 4 in 
maths and English; data not shown). However, more 
children had special educational needs (23·2% vs 17·1%), 
pupil absence rates were lower (4·4% vs 5·1%), and 
eligibility for free school meals was lower (12·4% vs 18·2%) 
in the cohort than the national average. 
Of the 1448 eligible participants, 1362 (94%) consented 
to participate in the study, of whom 1339 (98%) completed 
baseline assessments. The proportion of boys in the 
usual school provision group (42%) was lower than in 
each of the other two trial groups, but otherwise the 
groups were well balanced (table 1).
All nine FRIENDS sessions were delivered to classes 
assigned to both the health-led and school-led conditions. 
To assess intervention ﬁ delity, we recorded and in-
dependently rated 49 sessions (one from each class in the 
28 schools delivering FRIENDS). All speciﬁ ed core tasks 
and home activities were delivered in the 24 health-led 
sessions. In the school-led sessions, 15 of 25 (60%) 
delivered all core tasks and the home activity, eight (32%) 
delivered all except the home activity, and two (8%) did 
not deliver one core task and the home activity. Session 
attendance was not recorded although average school 
absence rates were very low (4·2% in the health-led group 
and 4·4% in the school-led group). 
We collected primary outcome data at 12 months from 
1257 (92%) of the children who completed baseline 
assessments (449 [92%] in the health-led group, 436 [92%] 
in school-led group, and 372 [93%] in the usual school 
provision). We recorded a signiﬁ cant diﬀ erence in adjusted 
mean RCADS at 12 months for health-led FRIENDS 
compared with school-led FRENDS (interaction co-
eﬃ  cient –3·91, 95% CI –6·48 to –1·35; p<0·0004) and 
usual school provision (–2·66, –5·22 to –0·09, p=0·043). 
The 95% CIs include our predeﬁ ned clinically important 
diﬀ erence of 3·6 points on the RCADS. Analysis of the 
RCADS subscales showed diﬀ erence in generalised and 
social anxiety, but not depression (table 2).
Analysis of other secondary outcomes and parent and 
teacher completed measures identiﬁ ed no diﬀ erences 
between treatment groups at 12 months (table 3).
As speciﬁ ed in the protocol, we did separate subgroup 
analysis in children with the highest 10% of baseline 
RCADS scores (high anxiety ≥49) and the remaining 90% 
(low anxiety ≤48; table 4).22
We recorded signiﬁ cant within-group reductions for 
the high-risk group at 12 months but no eﬀ ects between 
groups. For the low-risk group, we noted between-group 
diﬀ erences in mean RCADS at 12 months (table 4). 
Adjusted mean diﬀ erences showed an eﬀ ect for health-
led FRIENDS versus school-led FRIENDS (adjusted 
diﬀ erence –3·78, 95% CI –6·16 to –1·40; p=0·003) and 
health-led FRIENDS versus usual school provision 
(–3·13, –5·61 to –0·65; p=0·015). This eﬀ ect relates to a 
reduction in the health-led FRIENDS group on the social 
and generalised anxiety subscales (table 2).
 Health-led 
FRIENDS
School-led 
FRIENDS
Usual school 
provision
p value overall 
group eﬀ ect*
High anxiety† 
N 36 31 32 ··
Baseline 57·59 (8·18) 55·66 (7·16) 57·57 (7·90) 0·288
12 months 35·31 (19·24) 40·65 (21·40) 33·97 (21·15) 0·368
Low anxiety‡
N 374 (91·2%) 360 (92·1%) 295 (90·2%) ··
Baseline 22·78 (11·86) 22·01 (11·05) 22·51 (12·03) 0·623
12 months 17·68 (13·40) 21·06 (13·42) 20·74 (14·12) 0·006
Data are n (%) or mean (SD) unless otherwise indicated. RCADS=Revised Child Anxiety and Depression Scale. *Adjusted for 
sex, school, and baseline RCADS. †A total baseline RCADS score of 49 or more. ‡A total baseline RCADS score of 48 or less. 
Table 4: Subgroup analysis of primary outcome (child-completed total RCADS) for children with high and 
low anxiety
For Department of Education 
performance tables
see http://www.education.gov.
uk/schools/performance/archive/
index.shtml
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In the low anxiety group, the standardised eﬀ ect size 
of health-led FRIENDS compared with usual school 
provision (Cohen’s d=0·22, 95% CI 0·38–0·07) and 
school-led FRIENDS (0·25, 0·40–0·11) was small. The 
economic evaluation will be published separately. 
Discussion
This is the ﬁ rst large pragmatic randomised trial comparing 
a universally provided classroom-based cognitive behaviour 
therapy anxiety prevention pro gramme led by health and 
school staﬀ  with usual school provision. When we 
transferred health-led FRIENDS to everyday settings, the 
programme was more eﬀ ective in the reduction of child-
reported symptoms of anxiety than was school-led 
FRIENDS or usual school provision (panel 2). Although 
intervention leaders received the same initial training, our 
data suggest that a manualised programme might result in 
diﬀ erent outcomes depending on who delivers it. Although 
training teachers to deliver mental health programmes 
oﬀ ers a potentially convenient low-cost sustainable option, 
our results show that this approach is not as eﬀ ective as 
delivery by health professionals. 
Further exploration identiﬁ ed two potentially 
important diﬀ erences between health and school 
leaders. First, although treatment ﬁ delity was high, the 
home assignment was not undertaken in 40% of the 
school-led sessions that were assessed. Continuing 
practice of newly acquired skills is an integral part of 
cognitive behaviour therapy programmes and the 
absence of such practice might have compromised 
eﬀ ectiveness. However, this possibility needs to be 
balanced against the increased opportunities for class 
teachers to integrate and consolidate programme  skills 
more intensively through their daily contact with 
children. Second, although both groups had the same 
initial training, comparatively few teachers attended 
continuing supervision. Although teachers will be 
competent in some of the areas addressed in supervision 
(eg, classroom management and engaging children of 
diﬀ ering abilities), they will be less familiar with the 
underlying cognitive model. Therefore, scarce opportun-
ities to consolidate the theoretical model might have 
compromised programme delivery.
Children with high and low anxiety showed signiﬁ cant 
reductions in anxiety symptoms over time. The number 
of children with high anxiety was small and our study 
was not powered to compare between-group diﬀ erences 
within this subgroup. Therefore, the absence of between-
group diﬀ erences might be a power issue or might show 
regression to the mean. This issue needs to be clariﬁ ed 
in further suitably powered studies of highly anxious 
children. However, our cohort provided suﬃ  cient power 
to detect diﬀ erences within the low anxiety group in 
which we found a marked reduction between groups in 
favour of the health-led FRIENDS group. Universally 
delivered prevention programmes oﬀ er the potential to 
reduce present symptoms, enhance emotional wellbeing, 
and potentially shift population means over time. Our 
ﬁ ndings support this theory and show that children in 
the low-anxiety health-led FRIENDS group showed 
markedly lower anxiety symptoms at 12 months than did 
those in the usual school provision group. Because fears, 
anxiety, and stress are common in children, anxiety 
prevention programmes might be especially suited to 
universal delivery.16 Further research is needed to 
establish whether improvements are sustained in the 
medium term, and to detail the cost-eﬀ ectiveness of such 
universal interventions delivered by health professionals.
We recorded no diﬀ erences between groups for any 
secondary outcomes, suggesting that the intervention 
eﬀ ects were speciﬁ c to anxiety. The FRIENDS programme 
is designed as an anxiety prevention programme and 
speciﬁ cally develops skills known to reduce anxiety. 
Therefore, the speciﬁ c eﬀ ect that we identiﬁ ed is 
consistent with the underlying theoretical model and 
programme focus, although in view of the comorbidity 
between anxiety and depressive disorders and the shared 
elements of many cognitive behaviour programmes, this 
result is disappointing.35 Our ﬁ ndings show that although 
anxiety prevention programmes can have a positive eﬀ ect 
on anxiety symptoms, they cannot be assumed to 
enhance the general emotional wellbeing of children.
Panel 2: Research in context
Systematic review 
Findings of systematic reviews of school-based anxiety 
prevention programmes show that universally (ie, whole 
class) provided programmes based on cognitive behavioural 
therapy can be eﬀ ective.15,16,24 However, research methods are 
poor, adequately powered implementation trials are scarce, 
results are inconsistent, few medium term follow-ups exist, 
and direct comparison of school versus health-led delivery 
have seldom been undertaken. 
We aimed to undertake a suitably powered implementation 
trial of a school-based cognitive behaviour therapy anxiety 
prevention programme (FRIENDS) for children aged 
9–10 years. Programme delivery by health and school 
professionals was compared with treatment as usual at 
12 months. 
Interpretation 
Our results are consistent with those from systematic reviews 
that show that school-based anxiety prevention programmes 
informed by cognitive behaviour therapy are eﬀ ective in the 
reduction of anxiety in children. The programme leader is 
important because the programme we assessed was only 
eﬀ ective when delivered by health staﬀ . Our ﬁ nding that 
children with low symptoms also beneﬁ ted from the 
programme supports the use of universal approaches. This 
study supports the implementation of a universal anxiety 
prevention programme delivered by health professionals in 
regular schools in everyday settings.
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The eﬀ ect was also speciﬁ c to child report because 
although parent and teacher ratings reduced over time, 
these changes were not signiﬁ cant. This ﬁ nding might 
suggest that although children are feeling better, adults 
have not noticed any improvement in functioning or 
reduction in distress. However, only 42% of parents 
returned baseline questionnaires and as such these 
ﬁ ndings might not be representative of the total cohort. 
Similarly, the teacher assessment was global and might 
be insensitive to speciﬁ c changes in anxiety symptoms. 
Alternatively, the absence of a parent and teacher eﬀ ect 
might show the diﬃ  culty of assessment of changes in 
internal emotional symptoms and cognitions that are not 
directly observable.
The results of our study are consistent with those of 
reviews in which the intervention leader aﬀ ected 
programme eﬀ ectiveness,16 and with other imple-
mentation trials in which teacher-led FRIENDS was not 
eﬀ ective.36,37 Our ﬁ ndings diﬀ er to those of the study by 
Barrett and Turner,20 which directly compared teacher 
and psychologist delivery of FRIENDS, although their 
study lacked statistical power. Overall, our study 
supports the growing evidence base for the use of the 
FRIENDS programme as an eﬀ ective school-based 
anxiety prevention programme.16,24
The intervention that we assessed was based on 
cognitive behaviour therapy, which is typically used to 
treat mental health disorders. However, for school-
based universal emotional health programmes, most 
children will be healthy and will not need treatment. 
Furthermore, provision of individual treatment in a 
classroom context would not be appropriate. Therefore, 
it is important to emphasise that we did not provide 
treatment but used the cognitive behaviour therapy 
framework to help children to develop emotional, 
cognitive, and behavioural skills. Provision of life skills 
development within the school context ﬁ ts with the 
growing reognition that schools are not just concerned 
with the development of academic skills, but also have 
an important role in the enhancement of emotional 
development in children.
Our study has many strengths. We used a manualised 
anxiety prevention programme that has been shown to be 
eﬀ ective in schools and has been piloted in UK schools.16,25,26 
Recruitment and retention were high, absenteeism was 
low, and programme ﬁ delity was good. In terms of 
limitations, we relied on self-report measures and did not 
undertake any diagnostic interviews. Although anxiety 
symptoms were reduced in the health-led FRIENDS 
group, whether this reduction was indicative of changes 
in diagnostic status or impairment is unclear. Second, 
although our regional cohort included a representative 
sample of UK schools on several key dimensions, our 
group was less socially disadvantaged and had more white 
British participants than did the average UK state school. 
Therefore, whether similar results would be obtained with 
a more disadvantaged or ethnically diverse population is 
unclear. Similarly, although our schools were well matched 
across trial groups and our exploratory qualitative analysis 
identiﬁ ed few diﬀ erences in school culture and ethos, 
these diﬀ erences could have aﬀ ected outcomes. Third, 
although the health-led and school-led FRIENDS 
facilitators had the same initial training and treatment 
ﬁ delity was good, we did not directly assess how the 
intervention was delivered. Therefore, the diﬀ erences 
between these groups might be indicative of diﬀ erences in 
leader enthusiasm, conﬁ dence, and ability to engage and 
motivate students, which are skills that could be developed 
in school staﬀ  with additional training and supervision.16 
Finally, although we reported symptoms at 12 months, we 
were unable to estabish whether the improvements 
reported would be sustained over time. This point is 
especially important for prevention programmes in which 
the full extent of the preventive eﬀ ects might take several 
years to emerge.
In summary, our results are encouraging and show that 
anxiety prevention programmes delivered in schools to 
children aged 9–10 years do reduce anxiety symptoms at 
12 months. The ﬁ nding that children with low symptoms 
beneﬁ ted from the programme supports a universal 
approach, which also ﬁ ts well with school timetables and 
organisational structures.18 However, our data suggest that 
the same programme can result in diﬀ erent eﬀ ects 
depending on who delivers it. Further research is needed 
to explore the longer term eﬀ ect, and the potential 
mediators and moderators of anxiety prevention 
programmes, to assess cost-eﬀ ectiveness, and to establish 
whether anxiety prevention programmes are eﬀ ective 
with more diverse and disadvantaged groups.
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